ArticleScientific reports2024

Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infections.

Ye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.